case. The paravertebral abscess was associated to the disc involvement in 23 cases. Epiduritis was associated in 21 cases. Plain radiography, performed in in the majority of cases (63 cases, 94%), demonstrated pathological pictures in 56 (83.5%) patients. MRI, performed in 60 (89.5%) patients, disease was in all patients. Pathogens were isolated in 43 (64.1%) cases. Tuberculosis was the most common cause. The leading causative agents in non tuberculousspondylodiscitis were: Staphylococcus aureus (8 isolates, 11.9%), brucella (7 isolates, 10.4%), Escherichia coli (2 isolates, 2.9%) and streptococcus B (1 isolates, 1.4%).Two microorganisms combined (mycobacterium tuberculosis and a pyogenic) was found in one case. Medical treatment was adapted to the prescribed seed. Surgical treatment was performed in 6 patients. After therapy, 59 (88%) patients had regression of symptoms, two patients had a permanent neurological impairment (paraplegia), one patient had recurrence of infection and one patient was dead. Conclusions: Infectious spondylodiscitis has been diagnosed with increasing frequency. It should be taken into consideration in differential diagnosis in patients with significant back pain and laboratory evidence of an acute inflammatory process, especially metastatic spinal disease or inflammatory spondyloarthritis Objectives: To determine the clinical manifestations and outcomes of septic arthritis, find the factors associated with mortality, and discover the incidence of drug-resistant organisms in our institution Methods: A retrospective study was performed. Septic arthritis was defined as the presence of acute inflammatory arthritis indicated by a positive synovial fluid or synovial tissue culture for bacteria. A total of 116 septic arthritis patients, who visited Songklanagarind Hospital from January 2005 to December 2014, were reviewed. Results: The patient median age was 58 (IQR: 46, 72). Sixty-one patients (52%) were female. The median onset of symptoms and symptoms until diagnosis were 5 (IQR: 2, 7) and 6 (IQR: 3, 10) days, respectively. Eighty-eight cases (76.7%) had underlying diseases that might predispose to joint infection. Sixty-nine cases (59.5%) had pre-existing joint disease. Joint pain was the most common presenting symptom, and 58% of the cases had fever. The most common presentation was monoarthritis (87%), which was predominantly associated (78%) with knee joint involvement. The median synovial fluid leukocyte counts were 64,460 cells/μL (IQR: 30, 300; 129, 000) . Blood cultures were positive in 53 patients (49.1%). Synovial fluid cultures commonly had Streptococcus spp. growth (41%). Seven cases (7%) involved drug-resistant organisms. All of them either were diagnosed with septic arthritis during hospitalization or had a history of previous surgery. Twenty-five percent of the cases obtained the empirical antibiotic, ceftriaxone, and 86 patients (80%) underwent arthrotomy drainage. The mortality rate was 12%, and its associated factors were cancer, liver disease and advanced age. Conclusions: Streptococcus spp. is an emerging cause of septic arthritis in Southern Thai patients. Physicians should be aware of this in patients presenting with fever and acute monoarthritis, particularly those with comorbidities and underlying joint diseases. The proper empirical antibiotic of choice is ceftriaxone. Background: Fibromyalgia and spondyloarthritis can coexist and the overlap between the two diseases could have consequences on TNF inhibitors efficacy. Objectives: To evaluate TNF inhibitors efficacy in patients with axial spondyloarthritis fullfilling or not fibromyalgia criteria. Methods: Prospective observational bicentric study on 25 patients who met ASAS 2009 axial spondyloarthritis criteria. Fibromyalgia was defined by ACR 2010 fibromyalgia criteria or by a ≥5/6 score of the Fibromyalgia Rapid Screening Tool. Following items were recorded before and after a 6 months treatment with TNF inhibitors: Visual Analog Scale for pain and for patient global disease activity, values of ESR and CRP, number of tender joints, MASES score, number of Yunus tender points. All patients filled a self-questionnaire with BASDAI, BASFI, FiRST and ACR 2010 fibromyalgia scale items using SSS and WPI. Criterion of judgment: an ASAS partial remission state was compared in patients with or without fibromyalgia. Results: Of the 25 patients enrolled, 15 (60%) fulfilled ACR 2010 fibromyalgia criteria and 9 (36%) had a ≥5/6 FiRST score. The proportion of patients fulfilling an ASAS partial remission state was significantly lower in patients with fibromyalgia according to the ACR 2010 criteria (20% vs 70%, p=0,034) or to the FiRST score (0% vs 62,5%, p=0,0028). These patients had more severe disease activity and physical fonction than the patients without fibromyalgia. In this study, some factors were related with absence of ASAS partial remission: female gender, prior TNF inhibitor failure, ACR 2010 fibromyalgia criteria positivity, to have more than 11 Yunus points and to have a ≥5/6 FiRST score. Conclusions: Meeting the fibromyalgia criteria might have an impact on ASAS partial remission state and on efficacy of TNF inhibitors in patients with axial spondyloarthritis. The FiRST score was more specific to predict an absence of ASAS partial remission than the ACR 2010 fibromyalgia criteria. TNF inhibitors should be used with circumspection in case of FiRST score ≥5/6 in patients with axial spondyloarthritis.
References:
[1] Perrot S., Bouhassira D., Fermanian J., the CEDR (2010) showed a significant association of the fatigue severity with a limiting behaviour self-regulatory style of the patients, i.e. reducing daily activities and excessive resting. Objectives: The purpose of this cross-sectional study was to analyse the predictors of severity of fatigue in Italian patients with FM. Methods: Outpatients with a FM diagnosis who fulfilled both ACR /EULAR 1990 and 2010 criteria [3,4] , after a medical visit at the Fibromyalgia center at Sapienza University Hospital "Umberto I", were invited to participate in a study on their cognitions and behaviours wearing for one week a wrist actigraph (AMI Motionlogger Watch). Actigraphic sleep parameters were averaged over six days. After 7 days the participants returned the actigraph and answered a structured interview conducted by a trained psychologist which included validated scales measuring depression (Brief Symptom Inventory [5]), perceived fatigue (Checklist of Individual Strength [6]), sleep habits (Sleep Disorder Questionnaire [7] ) and behaviour regulation patterns (All-or-nothing and Limiting behaviour scales from Behavioural Responses to Illness Questionnaire [8] ). In the previous month and during the study, pharmacological and non-pharmacological treatments were unchanged. Results: Actigraphic monitoring and structured interview were completed by 39 female FM patients, with a mean age of 44.9 years (SD=8.55) and an illness mean duration of 6.5 years (SD=5.72). The majority of the patients reported insomnia complaints, and 29 (74.4%) met the DSM criteria for chronic insomnia. Fatigue severity resulted as the best subjective measure of fatigue, and was positively and significantly correlated with self-management through limiting behaviour, and with Total Time in Bed (TTB) measured through actigraphy. The correlation between TTB and Total Time Slept (TTS) and depression were not significant. Hierarchical regression considering TTB, Depression and Limiting behaviour, showed that all these variables give a significant independent contribution to the prediction of perceived severity of fatigue (47% of variance): limiting behaviour (β=0.52, p<0.01), TTB (β=0.31, p<0.05), Depression (β=0.29, p<0.05). Conclusions: These correlational findings suggest that self-regulation through limiting activity should be given priority attention in cognitive behavioural interventions aimed at reducing subjective fatigue. 
Methods:
The study population consisted of 101 consecutive male subjects referred to the Clinic for the Diagnosis and Therapy of Fibromyalgia, in the period between January 2007 and October 2016, matched with a control group of 101 females with CWP referred to the clinic in the same period. Complete clinical evaluation was performed in all patients. Results: Ninety-seven male subjects (96%) were referred to the clinic for a history of musculoskeletal pain, among these 53% reported fatigue and 60% complained about sleep disorders. A stressful trigger (work or family problems, bereavement, infections) at the onset of pain was reported by 42% of patients. Fifty-two percent of patients reported mood changes. Physical examination showed hyperalgesia in 15% of the subjects and a mean tender points' (TP) count was 4.6 (range 0-18). The diagnosis of FM was performed according to ACR 1990 criteria, since the enrollment included patients referred to the clinic before the publication of the latest ACR criteria [3, 4] . Only 18 male subjects (18%) fulfilled the classifying criteria. In the female group CWP was reported by 97%, fatigue by 65%, and sleep disorders by 72% of patients. Stressful events were reported by the 50% of female population. Mood changes were described by 54% of female subjects and were predominantly depressive. Physical examination revealed hyperalgesia in 48 subjects (47%) and the mean TP count was 11 (range 0-18). The diagnosis of FM was confirmed in 60% of subjects. Comparing the two cohorts of patients with FM, mean age at the time of the visit and mean age of onset of symptoms resulted significantly higher in females than in males (p=0.02 and p=0.04 respectively). There was no statistically significant difference in the number of TP, in fatigue, sleep and mood disorders and in the percentage of stressors considered as a trigger for the disease. Hyperalgesia was the only feature more common in females than in males (p=0.03). Conclusions: The significant higher frequency of hyperalgesia in women suggests a different presentation of CPW, that is the cornerstone of FM, in the two sexes. Moreover, the prevalence of FM was higher in females than in males when 1990 ACR criteria were used. It can be assumed that further gender differences could be showed applying 2010 ACR criteria. There was a significant association between JHS and FMS (p=.001), but not generalized joint laxity. Across all participants, dysautonomia symptoms correlated with Beighton score (r=.353 p=.032) and JHS participants reported higher heart rates during autonomic challenge (p=.002) and greater symptom burden (p=.001). The significant relationship between autonomic symptoms and maximum HR during tilt was fully mediated by presence of JHS or FMS (Figure 1 ). JHS partially mediated the relationship between FMS and increased anxiety scores and fully mediated the relationship between FMS and maximum HR during tilt (Figure 2 ).
Conclusions:
This study confirms that objective and subjective measures of dysautonomia are more common in FMS, and associated with JHS in this cohort, suggesting a common underlying mechanism which requires further exploration. We highlight the importance of assessing patients with FMS for both JHS and dysautonomia, which may inform further management of this often challenging condition.
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